Allstate Corporation’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
+13,963
New +$1.43M 0.01% 690
2022
Q1
Sell
-30,026
Closed -$1.56M 637
2021
Q4
$1.56M Sell
30,026
-1,953
-6% -$101K 0.03% 447
2021
Q3
$1.91M Sell
31,979
-46
-0.1% -$2.89K 0.08% 139
2021
Q2
$1.99M Sell
32,025
-7,772
-20% -$518K 0.07% 142
2021
Q1
$2.59M Sell
39,797
-44
-0.1% -$2.87K 0.08% 104
2020
Q4
$2.62M Buy
39,841
+2,024
+5% +$119K 0.08% 85
2020
Q3
$1.96M Buy
37,817
+1,125
+3% +$57.7K 0.06% 104
2020
Q2
$1.81M Hold
36,692
0.06% 129
2020
Q1
$1.87M Sell
36,692
-7,705
-17% -$444K 0.07% 123
2019
Q4
$2.45M Buy
+44,397
New +$2.41M 0.04% 257

Other funds holding EHC

Allstate Corporation's EHC Position: Q1 2026 in Review

Allstate Corporation opened a new position in Encompass Health (EHC) in Q1 2026: 13,963 shares worth $1.35M. The stake represents 0.01% of the portfolio and ranks #690 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in EHC as recently as Q4 2021.

Allstate Corporation first reported a position in EHC in Q4 2019 and has held it in 10 quarters since. The position peaked at $2.62M in Q4 2020. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Allstate Corporation held 13,963 shares of Encompass Health worth $1.35M as of Q1 2026.
  • Encompass Health was a new Allstate Corporation position in Q1 2026.
  • Encompass Health made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #690 holding.
  • Allstate Corporation first reported a position in Encompass Health in Q4 2019 and has held it in 10 quarters since.
  • Allstate Corporation's Encompass Health position peaked at $2.62M in Q4 2020.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.